RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bonus Biogroup Stock

Bonus Biogroup ROA 2024

Bonus Biogroup ROA

-0.52

Ticker

BONS.TA

ISIN

IL0004850116

WKN

A0Q9T6

In 2024, Bonus Biogroup's return on assets (ROA) was -0.52, a -39.92% increase from the -0.86 ROA in the previous year.

Bonus Biogroup Aktienanalyse

What does Bonus Biogroup do?

The Bonus Biogroup Ltd is a biotechnology company based in Israel that specializes in the development and marketing of innovative medical products and therapies based on human bone marrow stem cells. The company was founded in 2008 by a group of scientists, doctors, and entrepreneurs who came together to explore and develop new approaches in regenerative medicine. The business model of Bonus Biogroup is based on utilizing the benefits of stem cells for tissue and organ regeneration. Mesenchymal stem cells (MSC), derived from bone marrow, play an important role in this process. These stem cells have the ability to differentiate into various cell types and have anti-inflammatory properties. Bonus Biogroup aims to utilize MSC technology for the development of innovative medical products and therapies to help patients with serious diseases. The company is divided into several business areas, each offering its own products and services. A key area is the development of implants and other medical devices coated with bone marrow stem cells. These products are intended to promote tissue regeneration in the body, particularly in the treatment of bone and cartilage defects and joint diseases. An example is the BioGrip implant, used in patients with osteoporosis to prevent or reduce bone fractures. Another business area of Bonus Biogroup is the production and marketing of cell therapies. In this process, mesenchymal stem cells are obtained from the patient's bone marrow and processed in a special procedure. The stem cells are then directly injected into the affected area to promote tissue regeneration. These cell therapies are used in patients with rheumatism, arthritis, joint pain, or spinal problems. In addition to research and development of new products and therapies, Bonus Biogroup also operates a large stem cell bank. This bank collects and stores human bone marrow from donors for later use in the production of implants and cell therapies. The stem cell bank is a crucial part of the business model, as it ensures a consistent and high-quality supply of mesenchymal stem cells. In summary, Bonus Biogroup is an innovative biotechnology company specializing in the use of human bone marrow stem cells. The business model is based on the development and marketing of implants, cell therapies, and other medical devices to promote tissue regeneration in the body. The company also operates a large stem cell bank to ensure a consistent supply of high-quality mesenchymal stem cells. The company has the potential to become a significant player in regenerative medicine, making a valuable contribution to improving the health and quality of life of patients. Bonus Biogroup ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Bonus Biogroup's Return on Assets (ROA)

Bonus Biogroup's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Bonus Biogroup's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Bonus Biogroup's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Bonus Biogroup’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Bonus Biogroup stock

What is the Return on Assets (ROA) of Bonus Biogroup this year?

The Return on Assets (ROA) of Bonus Biogroup is -0.52 undefined this year.

What was the ROA of Bonus Biogroup compared to the previous year?

The ROA of Bonus Biogroup has increased by -39.92% compared to the previous year.

What consequences do high ROA have for investors of Bonus Biogroup?

A high ROA is advantageous for investors of Bonus Biogroup, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Bonus Biogroup?

A low ROA can be unfavorable for investors of Bonus Biogroup as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Bonus Biogroup affect the company?

An increase in ROA of Bonus Biogroup can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Bonus Biogroup impact the company?

A reduction in the ROA of Bonus Biogroup can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Bonus Biogroup?

Some factors that can influence the ROA of Bonus Biogroup include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Bonus Biogroup important for investors?

The ROA of Bonus Biogroup is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Bonus Biogroup take to improve ROA?

To improve ROA, Bonus Biogroup can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Bonus Biogroup pay?

Over the past 12 months, Bonus Biogroup paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bonus Biogroup is expected to pay a dividend of 0 ILS.

What is the dividend yield of Bonus Biogroup?

The current dividend yield of Bonus Biogroup is .

When does Bonus Biogroup pay dividends?

Bonus Biogroup pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bonus Biogroup?

Bonus Biogroup paid dividends every year for the past 0 years.

What is the dividend of Bonus Biogroup?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bonus Biogroup located?

Bonus Biogroup is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bonus Biogroup kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bonus Biogroup from 10/5/2024 amounting to 0 ILS, you needed to have the stock in your portfolio before the ex-date on 10/5/2024.

When did Bonus Biogroup pay the last dividend?

The last dividend was paid out on 10/5/2024.

What was the dividend of Bonus Biogroup in the year 2023?

In the year 2023, Bonus Biogroup distributed 0 ILS as dividends.

In which currency does Bonus Biogroup pay out the dividend?

The dividends of Bonus Biogroup are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bonus Biogroup

Our stock analysis for Bonus Biogroup Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bonus Biogroup Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.